Abstract
Abstract
Background
People with different types of dementia may have distinct symptoms and experiences that affect their quality of life. This study investigated whether quality of life varied across types of dementia and over time.
Methods
The participants were 1555 people with mild-to-moderate dementia and 1327 carers from the IDEAL longitudinal cohort study, recruited from clinical services. As many as possible were followed for up to 6 years. Diagnoses included were Alzheimer’s disease, vascular dementia, mixed Alzheimer’s and vascular dementia, Parkinson’s disease dementia, dementia with Lewy bodies, and frontotemporal dementia. Self- and informant-rated versions of the Quality of Life in Alzheimer’s Disease scale were used. A joint model, incorporating a mixed effects model with random effects and a survival model to account for dropout, was used to examine whether quality of life varied by dementia type at the time of diagnosis and how trajectories changed over time.
Results
The strongest associations between dementia type and quality of life were seen around the time of diagnosis. For both self-ratings and informant ratings, people with Parkinson’s disease dementia or dementia with Lewy bodies had lower quality of life scores. Over time there was little change in self-rated scores across all dementia types (− 0.15 points per year). Informant-rated scores declined over time (− 1.63 points per year), with the greatest decline seen in ratings by informants for people with dementia with Lewy bodies (− 2.18 points per year).
Conclusions
Self-rated quality of life scores were relatively stable over time whilst informant ratings showed a steeper decline. People with Parkinson’s disease dementia or dementia with Lewy bodies report particularly low levels of quality of life, indicating the importance of greater attention to the needs of these groups.
Funder
Economic and Social Research Council
National Institute for Health and Care Research
Alzheimer's Society
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Alzheimer’s Disease International. From plan to impact VII: dementia at a crossroads. London: Alzheimer’s Disease International; 2024.
2. World Health Organization: International classification of diseases, eleventh revision (ICD-11). Geneva, Switzerland: World Health Organization; 2019/2021.
3. Parasrampuria S, Bijelic E, Bott DM, Driessen J, Lipp MJ, Ling SM. Disaggregating the dementia monolith: an analysis of variation in Medicare costs and use by dementia subtype. Alzheimers Dement. 2023;19(8):3295–305. https://doi.org/10.1002/alz.12953.
4. Prince M, Knapp M, Guerchet M, McCrone P, Prina M, Comas-Herrera A, Wittenberg R, Adelaja B, Hu B, King D. Dementia UK: second edition - overview. London, England: Alzheimer’s Society. 2014.
5. Rizzo G, Arcuti S, Copetti M, Alessandria M, Savica R, Fontana A, Liguori R, Logroscino G. Accuracy of clinical diagnosis of dementia with Lewy bodies: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2018;89(4):358–66. https://doi.org/10.1136/jnnp-2017-316844.